Meeting
2019 ASCO Annual Meeting
Validation of broad panel clinical sequencing-based genomic risk stratification in patients with advanced lung adenocarcinomas.
Authors
Sam Whipple
Genentech, Inc., South San Francisco, CA
Sam Whipple , Axel Martin , Michael Martinec , Kathryn Cecilia Arbour , Venkatraman E. Seshan , Gregory J. Riely , Gracy Crane , Ronglai Shen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9113)
DOI
10.1200/JCO.2019.37.15_suppl.9113
Abstract #
9113
Poster Bd #
436
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer.
First Author: Kathryn C. Arbour
Poster
2019 ASCO Annual Meeting
Genomic characterization of lung tumors and metastatic (Met) sites in advanced (Adv) NSCLC.
First Author: Melinda D Willard
Poster
2023 ASCO Annual Meeting
Molecular characterization of resistance to immune checkpoint inhibitor and chemotherapy treatment in advanced non-small cell lung cancer.
First Author: Jordan Kardos
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi